Table 2.
Comparison of available studies in the literature
| Study | Irradiated liver metastases (n) | Nominal total dose/single dose (Gy) | BED2 (Gy) | Lesion size (ccm) | Median FU (months) | 1-year LC rate (%) |
|---|---|---|---|---|---|---|
| Katz et al., 2007 [21] |
69 |
30-55/2-6 |
40-73* |
0.1-950* |
14.5 |
76 |
| McCammon et al., 2009 [5] |
81 |
3 dose levels: |
3 levels*: |
2.8-370 |
8.2 |
|
| 1.) < 36/12 |
1.) 39 |
|
|
1.) 40 |
||
| 2.) 36-54/12-18 |
2.) 39-58 |
|
|
2.) 88 |
||
| 3.) 54/18 |
3.) 58 |
|
|
3.) 100 |
||
| Milano et al., 2008 [22] |
121 |
10-20/10-20 |
16-50 |
0.2-422 |
Not stated |
57 |
| Goodmann et al., 2010 [23] |
40 |
18-30/18-30 |
42-100* |
0.8-146 |
17 |
77 |
| Iwata et al., 2010 [24] |
12 |
50-55/5-5.5 |
62-71* |
0.9-22* |
14.5 |
86 |
| Rusthoven et al., 2009 [25] |
63 |
36-60/12-20 |
66-150* |
<113* |
16 |
95 |
| Lee et al., 2009 [26] |
68 |
42-60/7-10 |
59-100* |
1.19-3000 |
10.8 |
71 |
| Current series JBH et al. | 22 | 24-60/24-12 | 44-150 | 11-419 | 12 | 57 |
BED2 and PTV volumes were calculated by JBH et al. (V = 4/3πr3; median/range) in the cases marked with *.